Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
MedCity News is the leading online news source for the business of innovation in healthcare. We offer insight into what’s next and what matters with a mix of breaking news and analysis on startups, and established industry leaders, personalities, policies and the most important deals.
News
Kardigan's IPO Lands $400M for Drugs That Get to Root Causes of Heart Diseases
Kardigan was able to upsize its IPO, raising more cash for three drug candidates in mid-stage clinical development for cardiovascular conditions with no available therapies. All three programs are expected to report key data in 2027 that could pave the wa
Read more
Report
Angelini Pharma's $4B Acquisition Adds Rare Disease Drugs to a Global Growth Strategy
Angelini Pharma's acquisition of Catalyst Pharmaceuticals is part of a transformation strategy focused on neurological medicines. Catalyst's top product is Firdapse, the first FDA-approved drug for a particular rare neuromuscular disorder.
Read more
Report
AliveCor Isn't Backing Down from Apple, Its 'Bully'
AliveCor CEO Priya Abani argues that Apple has made a habit of taking intellectual property from smaller medical device firms in order to improve the functionalities its Apple Watch. She also believes that Apple has been able to avoid taking accountabilit
Read more
Report
How Often Do LLMs Hallucinate When Producing Medical Summaries? (Spoiler: A Lot)
Researchers at the University of Massachusetts Amherst released a paper this week showing that large language models tend to hallucinate quite a bit when producing medical summaries.
Read more
Report
Obesity is complex. Why aren't its treatments?
To get closer to the dream of personalized obesity treatments, we need more data to piece together which combinations of solutions work for which types of people.
Read more
Report
Pro access
Upgrade to see all 40 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.